Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian Cancer

This study has been withdrawn prior to enrollment.

( NYU 03-67 reached accrual prior to this study opening. )

Study NCT01017809 Information provided by New York University School of Medicine

First Received: November 19, 2009 Last Updated: May 18, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	December 2013
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)